Astronauts floating weightlessly in the International Space Station may appear carefree, but years of research have shown that microgravity causes changes to the human body. Spaceflight also means exposure to more radiation. Together, ...
Tags: Consumer Electronics, Health, Medicine
In research that could ultimately lead to many new medicines, scientists from the Florida campus of The Scripps Research Institute (TSRI) have developed a potentially general approach to design drugs from genome sequence. As a proof of ...
Tags: Identify New Drug Candidates, unparalleled selectivity, cell permeable
Ewing's Sarcoma is an aggressive pediatric cancer, most commonly caused by the improper fusion of the gene EWS with the gene FLI1. Though the cause has long been known, therapeutic targeting of this fusion has to date proven very difficult. ...
Tags: Ewing's Sarcoma, health, gene
What is ETMR/ETANTR and who does it affect? Embryonal tumours with multilayered rosettes (ETMR) are rare, deadly brain tumours that affect mainly children below the age of 4 years. There are 300 cases reported but probably there are many ...
At the annual Society for Laboratory Automation and Screening (SLAS) meeting Hamilton Robotics has announced a partnership with Coastal Genomics to launch the new Microlab® NIMBUS® Select workstation with Ranger Technology. The new ...
Rosetta Genomics, a provider of microRNA-based molecular diagnostics, has obtained a conditional approval from the New York State Department of Health (NYSDOH) for its Rosetta Kidney Cancer Test for testing on patient samples from the ...
Tags: Rosetta Kidney Cancer, Medicine
AstraZeneca has selected an undisclosed oncology target from Regulus Therapeutics as part of their strategic alliance in order to discover, develop and commercialize microRNA therapeutics. Both the companies have entered into a strategic ...
Firefly BioWorks has expanded its FirePlex miRSelect to enable multiplexed detection of up to 68 user-selected microRNA species in a single well of a 96 well plate from a maximum of 23. The new version of the company's product enables ...
Lab21 has entered into a collaboration agreement with IntegraGen for the development of a microRNA assay for colorectal cancer. Under the partnership, Lab21 will utilize its proprietary SPARQ PCR technology to develop a CE marked assay ...
Tags: colorectal cancer assay, IntegraGen, microRNA biomarker
Santaris Pharma and miRagen Therapeutics have extended their research deal to discover and develop LNA-drugs against disease causing microRNAs. The agreement allows miRagen to gain a non-exclusive license to the miRNA therapeutics field ...
National Institutes of Health(NIH),under the SHIFT initiative,has granted two Small Business Innovative Research(SBIR)Phase I awards,totaling$800k over 2 years,to Circulomics. Circulomics will use the grants to develop its Ligo-miR ...
Tags: NIH, SHIFT, SBIR, Ligo miR microRNA assay technology
Marina Biotech has won a patent in the US protecting unlocked nucleobase analog (UNA) modification and substitution chemistry. Patent broadly covers RNA-based oligonucleotide therapeutics such as a RNA duplex, a microRNA mimic, a microRNA ...
Tags: Marina Biotech, UNA, substitution chemistry
Genisphere and the Lankenau Institute for Medical Research (LIMR) will continue their colloboration on microRNA (miRNA) biomarker development for Ulcerative Colitis (UC) and will expand the partnership to include Crohn's Disease and other ...
Rosetta Genomics has won a European patent covering the use of miR-34a in the preparation of pharmaceuticals used to treat p53-negative cancers. The patent covers a core element of Rosetta's microRNA technology in the development of ...
Tags: European patent, p53-negative cancer, miR-34a, clinical technology